76.58
price up icon0.74%   0.56
 
loading

Nuvalent Inc Azioni (NUVL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- -25.30 8.70 8.10
Operating Expenses
10.29%
104.57
94.81 86.30 76.33 65.15
Operating Income/Loss
10.29%
-104.57
-94.81 -86.30 -76.33 -65.15
Nonoperating Income/Loss
51.26%
5.063
10.39 11.71 -7.974 8.154
Income/Loss From Continuing Operations Before Tax
17.87%
-99.51
-84.42 -74.59 -84.31 -57.00
Income Tax Expense/Benefit
7.64%
0.145
0.157 0.171 0.04 0.17
Income/Loss From Continuing Operations After Tax
17.82%
-99.65
-84.58 -74.76 -84.34 -57.17
Net Income/Loss
17.82%
-99.65
-84.58 -74.76 -84.34 -57.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.33%
71.84
71.61 1.5941 65.68 64.61
Diluted Average Shares
0.33%
71.84
71.61 1.5941 65.68 64.61
Basic Earnings Per Share
17.80%
-1.39
-1.18 -1.06 -1.28 -0.88
Diluted Earnings Per Share
17.80%
-1.39
-1.18 -1.06 -1.28 -0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Capitalizzazione:     |  Volume (24 ore):